Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Clin Cancer Res. 2010 Sep 16;16(21):5260–5268. doi: 10.1158/1078-0432.CCR-10-0994

Table 2.

Response to Treatment

Response No. of Patients
(N=35)
% Median % Change in
Average SUV (range)
Complete Response 1 3 −78.8%
(n=1)
Partial Response 10 28 −10.0% (−0.5 to −22.9)
(n=5)
Stable Disease Total
Stable Disease > 6 months
16
13
46
37
−13.9% (−34.4 to 11.5)
(n=12)
Progressive Disease 6 17 8.6% (−0.8 to 36.1)
(n=4)
Not Assessable 2 6 n =13
Objective Response Rate
 95% CI
11 31
(16 to 47)
Disease Control Rate
 95% CI
27 77
(63 to 91)
Disease Control by Histology
WDTC
MTC
22/28
5/7
78
71

Abbreviations: CI, Confidence Interval; WDTC, Well-differentiated thyroid cancer; MTC, Medullary thyroid cancer

Disease control rate includes patients with complete response, partial response, and stable disease at 3 months.